Dechra Pharmaceuticals PLC Director/PDMR Shareholding (7791Y)
March 07 2017 - 9:18AM
UK Regulatory
TIDMDPH
RNS Number : 7791Y
Dechra Pharmaceuticals PLC
07 March 2017
7 March 2017
Dechra Pharmaceuticals PLC
(the Company)
Director Shareholding
The Company announces that on 7 March 2017 Richard Cotton, Chief
Financial Officer, was granted the following awards over ordinary
shares of 1 pence each in the Company. Each award will vest,
subject to the satisfaction of a performance condition, on the date
specified below:
Type of award Number of shares Vesting date
subject to award
---------------- ------------------ ------------------
Nil cost option 21,033 3 January 2018
---------------- ------------------ ------------------
Nil cost option 21,033 15 September 2018
---------------- ------------------ ------------------
These are the recruitment awards referred to in the Company's
Directors' Remuneration Report for the year ended 30 June 2016.
The Notification of Dealing Forms set out below are provided in
accordance with the requirements of the EU Market Abuse
Regulation.
Notification of Dealing Form
1. Details of the Person Discharging Managerial
Responsibility ("PDMR")/person closely
associated with them ("PCA")
--- ------------------------------------------------------------
a) Name Richard Cotton
--- ----------------------------- -----------------------------
2. Reason for the notification
--- ------------------------------------------------------------
a) Position/status Director
--- ----------------------------- -----------------------------
b) Initial notification/ Initial Notification
amendment
--- ----------------------------- -----------------------------
3. Details of the Issuer
--- ------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
--- ----------------------------- -----------------------------
b) LEI code N/A
--- ----------------------------- -----------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ------------------------------------------------------------
a) Description Ordinary Shares of 1 pence
of the financial each
instrument ISIN: GB0009633180
Identification
code
--- ----------------------------- -----------------------------
b) Nature of Grant of nil cost options
the transaction
--- ----------------------------- -----------------------------
c) Price(s) and Price(s) Volume(s)
volumes(s)
Nil cost 21,033
Nil cost 21,033
--- ----------------------------- -------------- -------------
d) Aggregated N/A
information
* Aggregate volume
* Price
--- ----------------------------- -----------------------------
e) Date of the 2017.03.07
transaction
--- ----------------------------- -----------------------------
f) Place of the Outside a trading venue
transaction
--- ----------------------------- -----------------------------
For further information, please contact:
Suzana Cross, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is an international specialist veterinary pharmaceuticals
and related products business. Our expertise is in the development,
manufacture, and sales and marketing of high quality products
exclusively for veterinarians worldwide. Dechra's business is
unique as the majority of its products are used to treat medical
conditions for which there is no other effective solution or have a
clinical or dosing advantage over competitor products. For more
information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of
Dechra Pharmaceuticals PLC.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHOKODDPBKDANK
(END) Dow Jones Newswires
March 07, 2017 10:18 ET (15:18 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Apr 2024 to May 2024
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From May 2023 to May 2024